Scarica l'app Stockscreener
176.93
0.68%
1.19
Precedente Chiudi:
$175.74
Aprire:
$175.56
Volume 24 ore:
1.01M
Relative Volume:
1.10
Capitalizzazione di mercato:
$10.75B
Reddito:
$4.09B
Utile/perdita netta:
$-404.84M
Rapporto P/E:
-26.22
EPS:
-6.7469
Flusso di cassa netto:
$1.24B
1 W Prestazione:
+25.42%
1M Prestazione:
+28.68%
6M Prestazione:
+63.42%
1 anno Prestazione:
+41.43%
Intervallo 1D:
$173.73
$177.80
Intervallo di 1 settimana:
$162.60
$182.99
Portata 52W:
$95.49
$182.99
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
Nome
Jazz Pharmaceuticals Plc
Settore
Industria
Telefono
353-1-634-7800
Indirizzo
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Confronta JAZZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
176.93 | 10.68B | 4.09B | -404.84M | 1.24B | -6.7469 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Iniziato | Deutsche Bank | Buy |
| 2025-03-07 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | Iniziato | Goldman | Buy |
| 2024-01-03 | Iniziato | Robert W. Baird | Outperform |
| 2023-11-27 | Downgrade | UBS | Buy → Neutral |
| 2023-09-29 | Iniziato | Raymond James | Mkt Perform |
| 2023-06-12 | Ripresa | Wells Fargo | Equal Weight |
| 2022-12-09 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-06-14 | Iniziato | UBS | Buy |
| 2022-04-06 | Downgrade | Goldman | Buy → Neutral |
| 2021-11-19 | Ripresa | Goldman | Buy |
| 2021-10-07 | Ripresa | Jefferies | Buy |
| 2021-10-05 | Iniziato | Citigroup | Buy |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2021-05-19 | Ripresa | JP Morgan | Overweight |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2021-02-05 | Reiterato | H.C. Wainwright | Buy |
| 2021-02-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-11-03 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-14 | Downgrade | Goldman | Neutral → Sell |
| 2020-09-14 | Ripresa | JP Morgan | Overweight |
| 2020-08-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | Iniziato | Goldman | Neutral |
| 2019-08-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | Iniziato | Barclays | Overweight |
| 2019-03-20 | Iniziato | SunTrust | Buy |
| 2018-12-14 | Iniziato | Wolfe Research | Peer Perform |
| 2018-11-08 | Reiterato | B. Riley FBR | Buy |
| 2018-08-08 | Reiterato | Stifel | Buy |
| 2018-07-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | Reiterato | H.C. Wainwright | Neutral |
| 2018-03-19 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie
A Look at Jazz Pharmaceuticals's Valuation After Landmark HERIZON-GEA-01 Ziihera Trial Results - simplywall.st
Why Jazz Pharmaceuticals plc (J7Z) stock remains stableEarnings Performance Report & Verified Short-Term Plans - newser.com
What MACD trends signal for Jazz Pharmaceuticals plc (J7Z) stock2025 Winners & Losers & Capital Efficiency Focused Ideas - newser.com
How strong is Jazz Pharmaceuticals plc stock balance sheetJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Jazz Pharmaceuticals Insider Sold Shares Worth $3,259,538, According to a Recent SEC Filing - MarketScreener
Cozadd Bruce C, director at Jazz Pharmaceuticals, sells $3.2 million in stock By Investing.com - Investing.com South Africa
Insider Sell: Rick Winningham Sells 5,500 Shares of Jazz Pharmac - GuruFocus
Cozadd Bruce C, director at Jazz Pharmaceuticals, sells $3.2 million in stock - Investing.com India
Iannone, Jazz Pharmaceuticals EVP, sells $1.2m in JAZZ stock By Investing.com - Investing.com South Africa
Why Jazz Pharmaceuticals plc (J7Z) stock appeals to dividend investorsChart Signals & Entry Point Confirmation Alerts - newser.com
Is Jazz Pharmaceuticals plc (J7Z) stock undervalued at current priceQuarterly Growth Report & Stock Timing and Entry Methods - newser.com
Jazz Pharmaceuticals Insider Sold Shares Worth $1,204,573, According to a Recent SEC Filing - MarketScreener
Will Jazz Pharmaceuticals plc (J7Z) stock rise with strong economy2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
What technical charts say about Jazz Pharmaceuticals plc stockWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com
No-Moat Jazz's Growth Supported by Positive Phase 3 Data for Ziihera and Strong Uptake of Xywav - Morningstar
Insider Sell: Robert Iannone Sells Shares of Jazz Pharmaceuticals PLC - GuruFocus
Iannone, Jazz Pharmaceuticals EVP, sells $1.2m in JAZZ stock - Investing.com India
Will Jazz Pharmaceuticals plc (J7Z) stock outperform benchmarksRisk Management & Weekly Chart Analysis and Guides - newser.com
Technical analysis overview for Jazz Pharmaceuticals plc stockTrade Risk Assessment & Growth Focused Entry Point Reports - newser.com
Visual analytics tools that track Jazz Pharmaceuticals plc performanceMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Truist Adjusts Price Target on Jazz Pharmaceuticals Public to $220 From $205, Maintains Buy Rating - MarketScreener
Jazz Pharmaceuticals (JAZZ) Is Up 32.0% After Positive Phase 3 Results for Ziihera in HER2-Positive Cancer - simplywall.st
Can Jazz Pharmaceuticals plc stock resist sector downturnsWeekly Trade Review & Expert Verified Stock Movement Alerts - newser.com
Why Jazz Pharmaceuticals plc (J7Z) stock could be next leaderJuly 2025 Action & Community Consensus Picks - newser.com
Is Jazz Pharmaceuticals’ Rally A Buying Signal? - StocksToTrade
Single Trial Success Stories: UCB’s Kygevvi Joins US FDA Approvals With Confirmatory Evidence - Citeline News & Insights
Jazz Pharmaceuticals Plc Azioni (JAZZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):